5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Uridine: new trials by email Literature Review of Uridine trials Research Report on Uridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Uridine for Treatment of Bipolar Depression in Adolescents Uridine - Bipolar Disorder | Phase 2 | Completed | University of Utah | 42 | 2009-05-01 | 2018-03-26 |
| A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression RG2417, Placebo - Bipolar I Depression | Phase 2 | Completed | Repligen Corporation | 180 | 2008-11-01 | 2011-01-17 |
| Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression Uridine - Bipolar Depression | Phase 2 | Completed | Repligen Corporation | 80 | 2006-03-01 | 2007-11-09 |
| Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults NucleomaxX, Tenofovir Disoproxil Fumarate - HIV Infections, Lipodystrophy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2005-04-01 | 2017-06-07 |
| Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity ribose, thymidine, uridine - 5'-Nucleotidase Syndrome | Phase 2 | Completed | National Center for Research Resources (NCRR) | 1995-03-01 | 2005-06-24 |
Bipolar Disorder (3) · 5-Nucleotidase syndrome (1) · Depression (1) · HIV Infections (1) · Lipodystrophy (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nutrition Disorders (1) · Rare Diseases (1)
Repligen Corporation (2) · National Center for Research Resources (NCRR) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Utah (1)
United States (4)
Alice L. Yu (1) · David Jacoby, MD, PhD (1) · Douglas G Kondo, M.D. (1) · Gary Sachs, MD (1) · Grace A. McComsey, MD (1)
PMID 17538545, PMID 21486171, PMID 22293126
R01AI060484 (1), R01MH058681 (1)